PubMed · 2013 · 25 citations · 23 references
Life SciencesPathobiologyPathologyAutophagyEnzymologyMolecular PathologyEnzyme DeficienciesGlycogen MetabolismLysosomal DysfunctionLysosomal Storage DisordersMuscle DisordersMuscle PathologyEnzyme ActivityGlycogen AccumulationGlycogen Storage DiseasesGlycogen Storage Disorder Type IiResidual Enzyme ActivityRespiratory Failure PrognosisSkeletal Muscle AnatomySkeletal Muscle Physiology
Glycogenosis II (GSD II) is an autosomal recessive lysosomal storage disorder resulting from acid alpha-glucosidase deficiency, subsequent accumulation of glycogen in tissues, impairment of autophagic processes and progressive cardiac, motor and respiratory failure. The late-onset form is characterized by wide variability in residual enzyme activity, age of onset, rate of disease progression and phenotypical spectrum. Although the pathological process mainly affects the skeletal muscle, several other tissues may be involved in the course of the disease; therefore GSD II should be regarded as a multisystem disorder in which glycogen accumulation is present in skeletal and smooth muscle, heart, brain, liver, spleen, salivary glands, kidney and blood vessels. In this review, we briefly summarize the main non-muscle targets of the pathological process in late-onset GSD II. Further studies aimed at evaluating the extra-muscle involvement in this group of patients will help to better define clinical features and prognostic factors and to delineate the natural history of the disease.
23
Sleep-disordered breathing and respiratory failure in acid maltase deficiency
Uwe Mellies, R. Ragette, C. Schwake et al. · Neurology · 2001 · 162 citations
Pompe's disease: An inborn lysosomal disorder with storage of glycogen
J. J. Martin, Th. de Barsy, F. Van Hoof et al. · Acta Neuropathologica · 1973 · 126 citations
Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease
Pascal Laforêt, P. Petiot, Marc Nicolino et al. · Neurology · 2008 · 94 citations